These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18485101)

  • 21. Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice.
    Ji Y; Permanne B; Sigurdsson EM; Holtzman DM; Wisniewski T
    J Alzheimers Dis; 2001 Feb; 3(1):23-30. PubMed ID: 12214069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides.
    Munson GW; Roher AE; Kuo YM; Gilligan SM; Reardon CA; Getz GS; LaDu MJ
    Biochemistry; 2000 Dec; 39(51):16119-24. PubMed ID: 11123940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
    Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice.
    Kaya I; Jennische E; Lange S; Tarik Baykal A; Malmberg P; Fletcher JS
    J Neurochem; 2020 Jul; 154(1):84-98. PubMed ID: 32141089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
    O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
    Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E in Alzheimer's disease: an update.
    Yu JT; Tan L; Hardy J
    Annu Rev Neurosci; 2014; 37():79-100. PubMed ID: 24821312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells.
    Lahiri DK; Farlow MR; Sambamurti K
    Brain Res Mol Brain Res; 1998 Nov; 62(2):131-40. PubMed ID: 9813282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
    Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein.
    Irizarry MC; Deng A; Lleo A; Berezovska O; Von Arnim CA; Martin-Rehrmann M; Manelli A; LaDu MJ; Hyman BT; Rebeck GW
    J Neurochem; 2004 Sep; 90(5):1132-43. PubMed ID: 15312168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
    Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
    J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E genotype regulates amyloid-beta cytotoxicity.
    Wilhelmus MM; Otte-Höller I; Davis J; Van Nostrand WE; de Waal RM; Verbeek MM
    J Neurosci; 2005 Apr; 25(14):3621-7. PubMed ID: 15814793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
    Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
    Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease.
    Domínguez-Prieto M; Velasco A; Tabernero A; Medina JM
    J Alzheimers Dis; 2018; 65(4):1109-1124. PubMed ID: 30103329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
    Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
    J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice.
    Irizarry MC; Cheung BS; Rebeck GW; Paul SM; Bales KR; Hyman BT
    Acta Neuropathol; 2000 Nov; 100(5):451-8. PubMed ID: 11045665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice.
    Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM
    J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity.
    Yao ZX; Papadopoulos V
    FASEB J; 2002 Oct; 16(12):1677-9. PubMed ID: 12206998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology.
    Holtzman DM
    J Mol Neurosci; 2004; 23(3):247-54. PubMed ID: 15181253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.